ID

40944

Beschreibung

The primary focus of this first time in human (FTIH) study was to evaluate the safety and tolerability of GSK1292263 and to estimate GSK1292263 pharmacokinetic (PK) parameters and pharmacodynamic (PD) effects in healthy volunteers. Subject: FTIH, oral, safety, tolerability, pharmacokinetics, glucose, pharmacodynamics, male, female, gastric emptying Indication Studied: Type 2 Diabetes Mellitus Study ID: 111596 Clinical Study ID: 111596 Study Title: A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00783549 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK1292263, Sitagliptin Trade Name: N/A Study Indication: Dyslipidaemias

Stichworte

Versionen (2)
  1. 21.04.20 21.04.20 -
  2. 07.06.20 07.06.20 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

7. Juni 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin

Englisch

Logs and repeats Logs/Repeats 1

1 Formulare  
Date of visit/assessment
Beschreibung

Date of visit/assessment

Alias
UMLS CUI-1
C1320303
UMLS CUI-2
C2985720
Date of visit/assessment
Beschreibung

Date is the start of the study for this subject

Datentyp

date

Alias
UMLS CUI [1,1]
C1320303
UMLS CUI [1,2]
C2985720
Adverse event/concomitant medication/repeat assessment check questions
Beschreibung

Adverse event/concomitant medication/repeat assessment check questions

Alias
UMLS CUI-1
C0877248
UMLS CUI-2
C2347852
UMLS CUI-3
C0205341
UMLS CUI-4
C0220825
Were any concomitant medications taken by the subject during the study?
Beschreibung

concomitant medications

Datentyp

integer

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0681850
UMLS CUI [1,4]
C0347984
UMLS CUI [1,5]
C0008972
Did the subject experience any non-serious adverse events during the study?
Beschreibung

non-serious adverse events

Datentyp

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0681850
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C0008972
Did the subject experience any serious adverse events during the study?
Beschreibung

serious adverse events

Datentyp

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0681850
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C0008972
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
Beschreibung

abnormal ECG measurements

Datentyp

integer

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0008972
UMLS CUI [1,4]
C1832603
UMLS CUI [1,5]
C2985739
Were any repeat haematology, clinical chemistry or urinalysis samples taken?
Beschreibung

repeat haematology, clinical chemistry or urinalysis samples

Datentyp

integer

Alias
UMLS CUI [1,1]
C0008000
UMLS CUI [1,2]
C0200345
UMLS CUI [1,3]
C0205341
UMLS CUI [2,1]
C0018941
UMLS CUI [2,2]
C0200345
UMLS CUI [2,3]
C0205341
UMLS CUI [3,1]
C0042014
UMLS CUI [3,2]
C0200345
UMLS CUI [3,3]
C0205341
Were any repeat ECGs performed?
Beschreibung

repeat ECGs

Datentyp

integer

Alias
UMLS CUI [1,1]
C0013798
UMLS CUI [1,2]
C0205341
Were any repeat vital signs recorded?
Beschreibung

repeat vital signs

Datentyp

integer

Alias
UMLS CUI [1,1]
C0518766
UMLS CUI [1,2]
C0205341
Were any repeat PK blood samples taken?
Beschreibung

PK: pharmacokinetic

Datentyp

integer

Alias
UMLS CUI [1,1]
C1277698
UMLS CUI [1,2]
C0031327
UMLS CUI [1,3]
C0205341
Were any repeat PD samples taken?
Beschreibung

PD: Pharmacodynamic

Datentyp

integer

Alias
UMLS CUI [1,1]
C0205341
UMLS CUI [1,2]
C0851347
UMLS CUI [1,3]
C0200345
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Logs and repeats Logs/Repeats 1

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Date of visit/assessment
C1320303 (UMLS CUI-1)
C2985720 (UMLS CUI-2)
Date of visit/assessment
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
Item Group
Adverse event/concomitant medication/repeat assessment check questions
C0877248 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
C0205341 (UMLS CUI-3)
C0220825 (UMLS CUI-4)
Item
Were any concomitant medications taken by the subject during the study?
integer
C2347852 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
C0347984 (UMLS CUI [1,4])
C0008972 (UMLS CUI [1,5])
concomitant medications
Code List
Were any concomitant medications taken by the subject during the study?
CL Item
Yes (1)
CL Item
No (2)
Item
Did the subject experience any non-serious adverse events during the study?
integer
C1518404 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008972 (UMLS CUI [1,4])
non-serious adverse events
Code List
Did the subject experience any non-serious adverse events during the study?
CL Item
Yes (1)
CL Item
No (2)
Item
Did the subject experience any serious adverse events during the study?
integer
C1519255 (UMLS CUI [1,1])
C0681850 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008972 (UMLS CUI [1,4])
serious adverse events
Code List
Did the subject experience any serious adverse events during the study?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
integer
C0681850 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
C1832603 (UMLS CUI [1,4])
C2985739 (UMLS CUI [1,5])
abnormal ECG measurements
Code List
Were any abnormal, clinically significant ECG measurements recorded for this subject during the study?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat haematology, clinical chemistry or urinalysis samples taken?
integer
C0008000 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
C0018941 (UMLS CUI [2,1])
C0200345 (UMLS CUI [2,2])
C0205341 (UMLS CUI [2,3])
C0042014 (UMLS CUI [3,1])
C0200345 (UMLS CUI [3,2])
C0205341 (UMLS CUI [3,3])
repeat haematology, clinical chemistry or urinalysis samples
Code List
Were any repeat haematology, clinical chemistry or urinalysis samples taken?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat ECGs performed?
integer
C0013798 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
repeat ECGs
Code List
Were any repeat ECGs performed?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat vital signs recorded?
integer
C0518766 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
concomitant medications
Code List
Were any repeat vital signs recorded?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat PK blood samples taken?
integer
C1277698 (UMLS CUI [1,1])
C0031327 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
concomitant medications
Code List
Were any repeat PK blood samples taken?
CL Item
Yes (1)
CL Item
No (2)
Item
Were any repeat PD samples taken?
integer
C0205341 (UMLS CUI [1,1])
C0851347 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,3])
concomitant medications
Code List
Were any repeat PD samples taken?
CL Item
Yes (1)
CL Item
No (2)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video